PMC:7784830 / 13071-13484
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 216 | 182-185 | Disease | denotes | HPC | MESH:C537262 |
| 217 | 251-257 | Disease | denotes | cancer | MESH:D009369 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T3 | 251-257 | Phenotype | denotes | cancer | http://purl.obolibrary.org/obo/HP_0002664 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T107 | 0-413 | Sentence | denotes | CidofovirNanoparticles were prepared using poly(ethylene glycol)–polycaprolactone (PEG-PCL) To achieve its controlled release and also due to its wide spectrum anti-viral activity HPC a Printed using inkjet printer Combination of complexed anti cancer drug (Paclitaxel) and complexed anti viral drug (Cidofovir) were printed onto ODFsMechanical properties of film were enhanced due to drug printing [64,65] |